Do you want to read an article? Please log in or register.
The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort
Gout
Related content
COMMENTED
Rheumatoid Arthritis
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)
★ 2
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
doi: 10.1136/annrheumdis-2019-216819.
Gout
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Ann Rheum Dis.
Hammer HB, Karoliussen L, Terslev L, Haavardsholm EA, Kvien TK, Uhlig T
doi: 10.1136/annrheumdis-2020-217392.
Spinal Disorders
Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort
Rheumatology (Oxford).
Hirano F, van der Heijde D, van Gaalen FA, Landewé RBM, Gaujoux-Viala C, Ramiro S
doi: 10.1093/rheumatology/keaa353.
COMMENTED
Gout
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study
Arthritis Rheumatol.
Saag KG, Becker MA, Whelton A, Hunt B, Castillo M, Kisfalvi K, Gunawardhana L
doi: 10.1002/art.40685.
Systemic Sclerosis
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort
Swiss Med Wkly
Hernández J, Jordan S, Dobrota R, Iudici M, Hasler P, Ribi C, Villiger P, Vlachoyiannopoulos P, Vacca A, Garzanova L, Giollo A, Rosato E, Kötter I, Carreira PE, Doria A, Henes J, Müller-Ladner U, Smith V, Distler J, Gabrielli A, Hoffman-Vold AM, Walker U, Distler O, The Eustar Collaborators
doi: 10.4414/smw.2021.20528
Psoriatic Arthritis
Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
Arthritis Care Res (Hoboken).
Mease PJ, Gladman DD, Ogdie A, Coates LC, Behrens F, Kavanaugh A, Mcinnes I, Queiro R, Guerette B, Brunori M, Teng L, Smolen JS
doi: 10.1002/acr.24134.
Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Semin Arthritis Rheum.
Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M, Erra A, Serrat M, Espartal E, Antón S, Añez GA, Caparrós-Ruiz R, Pluma A, Trallero-Araguás E, Barceló-Bru M, Almirall M, De Agustín JJ, Segura JL, Julià A, Marsal S
doi: 10.1016/j.semarthrit.
Gout
Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis
Semin Arthritis Rheum
Son CN, Stewart S, Su I, Mihov B, Gamble G, Dalbeth N
doi: 10.1016/j.semarthrit.2021.04.011
Further Publications Dermatology
Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey
J Eur Acad Dermatol Venereol
Maurer M, Caballero T, Aberer W, Zanichelli A, Bouillet L, Bygum A, Grumach AS, Botha J, Andresen I, Longhurst HJ, IOS Study Group.
doi: 10.1111/jdv.17654